Published in J Antibiot (Tokyo) on February 01, 2007
A comprehensive review of glycosylated bacterial natural products. Chem Soc Rev (2015) 1.13
Nine enzymes are required for assembly of the pacidamycin group of peptidyl nucleoside antibiotics. J Am Chem Soc (2011) 1.04
SsaA, a member of a novel class of transcriptional regulators, controls sansanmycin production in Streptomyces sp. strain SS through a feedback mechanism. J Bacteriol (2013) 0.87
Muraymycin nucleoside-peptide antibiotics: uridine-derived natural products as lead structures for the development of novel antibacterial agents. Beilstein J Org Chem (2016) 0.77
Precursor-directed biosynthesis of new sansanmycin analogs bearing para-substituted-phenylalanines with high yields. J Antibiot (Tokyo) (2016) 0.77
Sansanmycin natural product analogues as potent and selective anti-mycobacterials that inhibit lipid I biosynthesis. Nat Commun (2017) 0.76
Draft genome sequence of Streptomyces sp. strain SS, which produces a series of uridyl peptide antibiotic sansanmycins. J Bacteriol (2012) 0.76
Improving the N-terminal diversity of sansanmycin through mutasynthesis. Microb Cell Fact (2016) 0.75
Identification of novel mureidomycin analogues via rational activation of a cryptic gene cluster in Streptomyces roseosporus NRRL 15998. Sci Rep (2015) 0.75
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med (2004) 3.92
DH166, a beta-carboline derivative, inhibits the kinase activity of PLK1. Cancer Biol Ther (2009) 1.42
Sansanmycins B and C, new components of sansanmycins. J Antibiot (Tokyo) (2008) 0.93
Two novel nucleosidyl-peptide antibiotics: Sansanmycin F and G produced by Streptomyces sp SS. J Antibiot (Tokyo) (2010) 0.91
NRPS substrate promiscuity leads to more potent antitubercular sansanmycin analogues. J Nat Prod (2014) 0.88
Discovery of antagonists for human scavenger receptor CD36 via an ELISA-like high-throughput screening assay. J Biomol Screen (2010) 0.87
SsaA, a member of a novel class of transcriptional regulators, controls sansanmycin production in Streptomyces sp. strain SS through a feedback mechanism. J Bacteriol (2013) 0.87
Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner. Atherosclerosis (2012) 0.87
Identification of a mutant α1 Na/K-ATPase that pumps but is defective in signal transduction. J Biol Chem (2013) 0.85
Identification of upregulators of human ATP-binding cassette transporter A1 via high-throughput screening of a synthetic and natural compound library. J Biomol Screen (2008) 0.85
Identification of trichostatin A as a novel transcriptional up-regulator of scavenger receptor BI both in HepG2 and RAW 264.7 cells. Atherosclerosis (2008) 0.85
Preliminary report on the biological effects of space flight on the producing strain of a new immunosuppressant, Kanglemycin C. J Ind Microbiol Biotechnol (2006) 0.84
Identification of two antagonists of the scavenger receptor CD36 using a high-throughput screening model. Anal Biochem (2010) 0.83
Identification of antituberculosis agents that target ribosomal protein interactions using a yeast two-hybrid system. Proc Natl Acad Sci U S A (2012) 0.83
Expression of mutant α1 Na/K-ATPase defective in conformational transition attenuates Src-mediated signal transduction. J Biol Chem (2013) 0.82
In vitro interactions of calcineurin inhibitors with conventional antifungal agents against the yeast form of Penicillium marneffei. Mycopathologia (2014) 0.82
Molecular target of piperine in the inhibition of lipid droplet accumulation in macrophages. Biol Pharm Bull (2008) 0.82
DH334, a beta-carboline anti-cancer drug, inhibits the CDK activity of budding yeast. Cancer Biol Ther (2007) 0.81
A series of beta-carboline derivatives inhibit the kinase activity of PLKs. PLoS One (2012) 0.79
Identification of a selective agonist for liver X receptor α (LXRα) via screening of a synthetic compound library. J Biomol Screen (2013) 0.79
A marine-derived Streptomyces sp. MS449 produces high yield of actinomycin X2 and actinomycin D with potent anti-tuberculosis activity. Appl Microbiol Biotechnol (2012) 0.79
Identification of dehydroxytrichostatin A as a novel up-regulator of the ATP-binding cassette transporter A1 (ABCA1). Molecules (2011) 0.79
Two thiophenes compounds are partial peroxisome proliferator-activated receptor α/γ dual agonists. Biol Pharm Bull (2011) 0.79
Streptothricin derivatives from Streptomyces sp. I08A 1776. J Nat Prod (2011) 0.78
Identification of hydroxyxanthones as Na/K-ATPase ligands. Mol Pharmacol (2010) 0.78
19-[(1'S,4'R)-4'-Hydroxy-1'-methoxy-2'-oxopentyl]geldanamycin, a natural geldanamycin analogue from Streptomyces hygroscopicus 17997. J Nat Prod (2013) 0.77
Structural basis of human transcription factor Sry-related box 17 binding to DNA. Protein Pept Lett (2013) 0.77
Identification of novel human high-density lipoprotein receptor Up-regulators using a cell-based high-throughput screening assay. J Biomol Screen (2007) 0.77
Mycophenolic acid induces ATP-binding cassette transporter A1 (ABCA1) expression through the PPARγ-LXRα-ABCA1 pathway. Biochem Biophys Res Commun (2011) 0.77
Expression, purification, crystallization and preliminary X-ray crystallographic analysis of the hyperthermophilic nucleotidyltransferase TTHA1015 from Thermus thermophilus HB8. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.76
Overexpression, purification, crystallization and preliminary crystallographic studies of a hyperthermophilic adenylosuccinate synthetase from Pyrococcus horikoshii OT3. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.76
Draft genome sequence of Streptomyces sp. strain SS, which produces a series of uridyl peptide antibiotic sansanmycins. J Bacteriol (2012) 0.76
How can high-throughput screening deliver drugs to treat atherosclerosis? Expert Opin Drug Discov (2010) 0.75
The antituberculosis antibiotic capreomycin inhibits protein synthesis by disrupting interaction between ribosomal proteins L12 and L10. Antimicrob Agents Chemother (2014) 0.75
Identification of upregulators of BMP2 expression via high-throughput screening of a synthetic and natural compound library. J Biomol Screen (2009) 0.75
A small molecule, MTBT, prevents cancer cell growth by activating p38 MAPK. Anticancer Drugs (2014) 0.75
Induction of apoptosis by the angucyclinone antibiotic chemomicin in human tumor cells. Oncol Rep (2010) 0.75
Mechanisms of the antitumor action of the new antibiotic NC0604, a member of the bleomycin family. Oncol Rep (2010) 0.75
IMB2026791, a xanthone, stimulates cholesterol efflux by increasing the binding of apolipoprotein A-I to ATP-binding cassette transporter A1. Molecules (2012) 0.75
The molecular target of rubimaillin in the inhibition of lipid droplet accumulation in macrophages. Biol Pharm Bull (2009) 0.75
Isolation and characterization of antibiotic NC0604, a new analogue of bleomycin. J Antibiot (Tokyo) (2008) 0.75
The mechanism of action of bufalin in inhibition of lipid droplet accumulation in mouse macrophages. Biol Pharm Bull (2013) 0.75
Potent antitumor actions of the new antibiotic boningmycin through induction of apoptosis and cellular senescence. Anticancer Drugs (2011) 0.75
Corrigendum: Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis. Sci Rep (2015) 0.75
4862F, a new inhibitor of HIV-1 protease, from the culture of Streptomyces I03A-04862. Molecules (2012) 0.75
[Effects of angustmycin on callus occurrence and proliferation of Panax notogingseng in vitro]. Zhong Yao Cai (2004) 0.75